Evaluation of strategies to modify Anti-SARS-CoV-2 monoclonal antibodies for optimal functionality as therapeutics. House RV, Broge TA, Suscovich TJ, Snow DM, et al. PLoS One 2022;17:e0267796.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

House RV, Broge TA, Suscovich TJ, Snow DM, et al. Evaluation of strategies to modify Anti-SARS-CoV-2 monoclonal antibodies for optimal functionality as therapeutics. PLoS One 2022;17:e0267796.
PMID: 35657812